Brand / product

Amprexa-F

Olanzapine + Fluoxetine · 12 mg + 25 mg

₨ Official source-observed price PKR 536.97 10's

PKR 53.70 / capsule

✓ Official DRAP price source observed · Source checked 2026-09-23

Price Intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →

This brandPKR 53.70/ capsule

Price position7% above medianvs like-for-like peer median

Peer comparators6current-price listings

🔒

MedInfoBase Pharma Pro

Unlock the full competitive price benchmark

See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.

Rank & percentilePeer medianFull competitor listPortfolio intelligence

View Price Intelligence PRO

Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.

Product details

Generic: Olanzapine + Fluoxetine
Therapeutic area: CNS & mental health
Drug class: Antipsychotics
ATC: N06CA
Strength: 12 mg + 25 mg
Dosage form: Capsule
Pack: 10's
Registration no.: 076751
Price record verified: 2026-08-08
Latest DRAP source check: 2026-09-23 03:19

Manufacturer

Amarant Pharmaceuticals Private Limited

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →

Price movement

Official price over time

No change in the official DRAP price is recorded for this pack (10's). Current price PKR 536.97, effective 23 Jul 2026.

Cite this price history

MedInfoBase. Amprexa-F 12 mg + 25 mg, 10's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/amprexa-f-12-mg-25-mg-076751-10s-amarant-pharmaceuticals-private-limited-3743/ (accessed 24 September 2026).

Traceability

Official price history

Amount	Effective from	Verified	Source	Status
PKR 536.97	2026-07-23	2026-09-22	DRAP PharmaPrice Index (recovered from snapshot #84)	Current

Same generic

Other listed brands

Alphado 25 mg + 6 mgNAVEGAL LABORATORIES · PKR 288.07 Amprexa-F 12 mg + 25 mgAmarant Pharmaceuticals Private Limited · PKR 1,480.82 Amprexa-F 6 mg + 25 mgAmarant Pharmaceuticals Private Limited · PKR 888.09 Amprexa-F 6 mg + 25 mgAmarant Pharmaceuticals Private Limited · PKR 450.23 Co-Deeprex 3 mg + 25 mgArreta Pharmaceuticals (Pvt.) Ltd. · PKR 515.75 Co-Deeprex 3 mg + 25 mgArreta Pharmaceuticals (Pvt.) Ltd. · PKR 260.88 Co-Deeprex Plus 6 mg + 25 mgArreta Pharmaceuticals (Pvt.) Ltd. · PKR 437.48 Co-Depricap 6 mg + 25 mgNabiqasim Industries (Pvt) Ltd., · PKR 362.43

Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.

Cite this record

Medicine record · DRAP registration 076751

MedInfoBase. (2026). Amprexa-F 12 mg + 25 mg Capsule (10's), Amarant Pharmaceuticals Private Limited — registration and price record [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/brand/amprexa-f-12-mg-25-mg-076751-10s-amarant-pharmaceuticals-private-limited-3743/ Data observed 22 September 2026. Source: DRAP PharmaPrice Index (recovered from snapshot #84). DRAP registration 076751.

Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.